Keywords: Bristol-Myers, Pfizer, Eliquis, PDUFA date, USA, FDA, Atrial fibrillation

FDA sets March 2013 PDUFA date for re-submitted Eliquis

Article | 28 September 2012

Print This

The US Food and Drug Administration has acknowledged receipt of the New Drug Application resubmission for pharma major Bristol-Myers Squibb ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in